MID-VOLUME · HOSP-HEAVY
nebivolol Side Effects
nebivolol (also sold as Bystolic) sits MID-VOLUME #272 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 56.3% mention hospitalization (8,438 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 14,997
- FAERS reports
FDA Adverse Event Reporting System extract for nebivolol. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
nebivolol: 56.3% mention hospitalization (8,438 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #272 of 524 by FAERS report count.
Mid-book FAERS page for nebivolol (Bystolic) (14,997 reports). Signature HOSP-HEAVY. Dominant age band on file: 75+. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ACUTE KIDNEY INJURY leads 922 of 14,997 reports
Who reports · age peak 75+ (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 75+ (4,405 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (1,464 reports, 9.8%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 184 |
| ACUTE KIDNEY INJURY | 165 |
| COMPLETED SUICIDE | 123 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 91 |
| PNEUMONIA | 88 |
| DYSPNOEA | 75 |
| ANAEMIA | 72 |
| CARDIAC FAILURE | 72 |
| DIARRHOEA | 67 |
| CARDIAC ARREST | 60 |
| LACTIC ACIDOSIS | 58 |
| RESPIRATORY FAILURE | 54 |
| TOXICITY TO VARIOUS AGENTS | 54 |
| SEPSIS | 53 |
| PYREXIA | 52 |
| RENAL FAILURE | 52 |
| ASTHENIA | 50 |
| COMA | 50 |
| HYPOTENSION | 46 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (8,438, 56.3% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| ACUTE KIDNEY INJURY | 710 |
| DYSPNOEA | 494 |
| ANAEMIA | 469 |
| DIARRHOEA | 441 |
| HYPOTENSION | 423 |
| FALL | 417 |
| DRUG INTERACTION | 358 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 343 |
| NAUSEA | 304 |
| VOMITING | 289 |
| ASTHENIA | 284 |
| HYPONATRAEMIA | 281 |
| PYREXIA | 280 |
| PNEUMONIA | 267 |
| BRADYCARDIA | 247 |
| DIZZINESS | 246 |
| FATIGUE | 235 |
| SYNCOPE | 231 |
How to read nebivolol FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 14,997 voluntary reports linked to nebivolol (Bystolic), 2004-2025. Death is listed on 1,464 (9.8%). Hospitalization appears on 8,438 (56.3%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 56.3% mention hospitalization (8,438 reports).
Read with nebivolol
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 14,954 FAERS cases (Δ 43 lighter vs nebivolol); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 14,896 FAERS cases (Δ 101 lighter vs nebivolol); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 15,113 FAERS cases (Δ 116 heavier vs nebivolol); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 14,664 FAERS cases (Δ 333 lighter vs nebivolol); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 52.3 pp vs nebivolol's DEATH-HEAVY): CASELOAD · HOSP-MID.
nebivolol stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.